Target intelligence / Profile preview

Immunoglobulin superfamily member 9B (IGSF9B)

Target
IGSF9B
Molecular classification
Cell adhesion molecule, Immunoglobulin superfamily domain containing protein, Fibronectin type III domain containing protein
01

Overview

Immunoglobulin superfamily member 9B (IGSF9B) is an evolutionarily conserved, brain‐specific cell adhesion molecule selectively localized to inhibitory synapses of GABAergic interneurons. It organizes distinct subsynaptic domains and interacts with synaptic organizers such as Neuroligin-2 through scaffolding molecules like S-SCAM/MAGI-2, supporting inhibitory synapse development and maintenance[1][2][3]. IGSF9B shows activity-dependent, cell type-specific expression in the brain and is involved in the regulation of inhibitory postsynaptic potential, synaptic transmission, and neural circuit plasticity. Genetic variants in IGSF9B have been associated with neuropsychiatric disorders including schizophrenia and major depression, as well as with neurodevelopmental circuit changes and anxiety behaviors in animal models. To date, IGSF9B is not a classical pharmacological target but remains of interest in neuroscience for understanding inhibitory synaptic architecture and brain disease mechanisms[1][2][3].

Other names
IGSF9BProtein turtle homolog BKIAA1030IgSF9BLINC00947LOC283174Immunoglobulin superfamily member 9BTurtle (Drosophila) homolog BMIR4697HGMIR4697 host gene (non-protein coding)Long intergenic non-protein coding RNA 947
02

Biological functions

Synaptic membrane adhesionHomophilic cell adhesionPositive regulation of inhibitory postsynaptic potentialOrganization and maintenance of inhibitory synapsesRegulation of synaptic transmission and plasticityNeurodevelopment and neuronal circuit maturation
03

Disease associations

Neuropsychiatric disorders (e.g., schizophrenia, major depressive disorder, bipolar disorder, autism spectrum disorder)Anxiety disordersPossible role in neurodegenerative diseases (e.g., Parkinson’s disease, based on genetic association studies)

Beyond the preview

Go deeper on Immunoglobulin superfamily member 9B (IGSF9B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin superfamily member 9B (IGSF9B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call